SenesTech, Inc. (NASDAQ:SNES) Short Interest Down 18.4% in August

Posted by MarketBeat News on Sep 17th, 2023

SenesTech, Inc. (NASDAQ:SNES – Get Free Report) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 27,100 shares, a decrease of 18.4% from the August 15th total of 33,200 shares. Based on an average daily volume of 27,600 shares, the short-interest ratio is presently 1.0 days. Currently, 1.0% of the shares of the stock are short sold.

SenesTech Stock Performance

Shares of SNES stock remained flat at $0.50 during trading hours on Friday. 82,245 shares of the stock traded hands, compared to its average volume of 38,902. The firm has a 50 day moving average price of $0.77 and a 200 day moving average price of $1.19. SenesTech has a 12-month low of $0.45 and a 12-month high of $11.20.

SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings data on Thursday, August 10th. The company reported ($0.70) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.08. The business had revenue of $0.31 million during the quarter, compared to the consensus estimate of $0.36 million. SenesTech had a negative return on equity of 240.76% and a negative net margin of 813.27%. As a group, sell-side analysts forecast that SenesTech will post -3.81 earnings per share for the current fiscal year.

Analyst Ratings Changes

Want More Great Investing Ideas?

Separately, StockNews.com upgraded SenesTech to a “sell” rating in a report on Thursday, May 25th.

Check Out Our Latest Analysis on SNES

Hedge Funds Weigh In On SenesTech

An institutional investor recently bought a new position in SenesTech stock. Armistice Capital LLC purchased a new position in shares of SenesTech, Inc. (NASDAQ:SNES – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 72,130 shares of the company’s stock, valued at approximately $223,000. Armistice Capital LLC owned approximately 11.82% of SenesTech as of its most recent filing with the SEC. 22.49% of the stock is currently owned by hedge funds and other institutional investors.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. SenesTech, Inc was incorporated in 2004 and is headquartered in Phoenix, Arizona.